# Endocalyx in Treatment Resistent Hypertension

> **NCT06940011** · PHASE2 · RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 64 (estimated)

## Conditions studied

- Treatment Resistant Hypertension

## Interventions

- **DIETARY_SUPPLEMENT:** Endocalyx Pro
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06940011
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-21
- **Primary completion:** 2027-12-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2025-04-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06940011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06940011, "Endocalyx in Treatment Resistent Hypertension". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06940011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*